It would have been a lot worse without the interventions
In the long reckoning with British Columbia's opioid crisis, a new study offers something rare: evidence that a quiet, widely distributed intervention has been holding back an even greater wave of loss. Researchers at the B.C. Centre for Disease Control found that take-home naloxone kits, dispensed through 2,400 sites across the province, prevented roughly 78 percent of what would otherwise have been fatal overdoses between 2019 and 2024. Against a backdrop of 12,356 deaths and a drug supply that grew more lethal through the pandemic years, the study asks us to reckon not only with what was lost, but with what was spared — and why that distinction matters for how societies choose to respond to suffering.
- B.C.'s opioid crisis reached its deadliest point in 2023, with 2,593 fatal overdoses in a single year — yet researchers say the toll would have climbed far higher without harm reduction infrastructure already in place.
- A new BCCDC study quantifies what prevention often cannot show: take-home naloxone kits averted approximately 1,000 death events per 100,000 people at risk over five years, making the invisible visible.
- Demand for naloxone kits surged twentyfold between 2016 and 2017, and the program now spans pharmacies, emergency rooms, correctional facilities, and supervised consumption sites — a sprawling network built around a single fast-acting drug.
- Early 2026 data shows fatal overdoses falling — 522 deaths in the first four months compared to 840 in the same window two years prior — but Canada's chief public health officer warns the illicit drug supply remains dangerously unpredictable.
- Researchers and officials alike are navigating the challenge of sustaining public and political will for harm reduction when progress is fragile, evidence is complex, and headlines tend to count the dead rather than the living.
Between 2019 and 2024, British Columbia recorded 12,356 fatal overdoses — nearly 2,500 deaths per year at the crisis's peak. But a new study from the B.C. Centre for Disease Control suggests the toll would have been far steeper without take-home naloxone kits, which the research found prevented 78 percent of what would otherwise have been fatal poisonings over that five-year period.
The study was led by Dr. Mike Irvine, a senior data analytics scientist at the BCCDC. The naloxone distribution program, established in 2012, now operates through 2,400 sites across the province — overdose prevention centres, supervised consumption sites, emergency rooms, pharmacies, correctional facilities, and community organizations. Irvine deliberately focused on 2019 to 2024, years that spanned the COVID-19 pandemic's disruption to care systems and coincided with an increasingly lethal illicit drug supply. The worst year was 2023, with 2,593 deaths.
The research examined the full harm reduction ecosystem — take-home kits, overdose prevention sites, supervised consumption sites, and opioid agonist treatment together. Kits distributed through overdose prevention and supervised consumption sites were found to be far more likely to be used in an actual emergency. Community programs alone averted roughly 1,000 death events per 100,000 people at risk.
Irvine acknowledged the challenge of communicating impact when public attention gravitates toward rising death counts rather than lives spared. He was measured about whether the study would shift public perception, noting that evidence can only strengthen the conversation policymakers and communities need to have.
Recent data offers cautious encouragement. Fatal overdoses in the first four months of 2026 fell to 522, down from 617 in the same period of 2025 and 840 in early 2024. Nationally, opioid-related deaths dropped 23 percent from 2024 to 2025. Canada's chief public health officer, Dr. Joss Reimer, credited expanded naloxone access and improved surveillance of illicit drug supplies — while warning that the illegal supply remains toxic and the progress, however real, remains fragile.
Between 2019 and 2024, British Columbia recorded 12,356 fatal overdoses. That number alone carries weight—nearly 2,500 deaths per year at the crisis's peak. But a new study from the B.C. Centre for Disease Control suggests the actual toll would have been far steeper without one simple intervention: take-home naloxone kits.
The research, led by Dr. Mike Irvine, a senior scientist in data analytics at the BCCDC, found that naloxone—a fast-acting medication that temporarily reverses opioid overdose effects—prevented 78 percent of what would have been fatal poisonings during that five-year window. The program that distributes these kits, established in 2012, now operates through 2,400 sites across the province: overdose prevention centers, supervised consumption sites, emergency rooms, health clinics, correctional facilities, community organizations, and pharmacies. Between 2016 and 2017 alone, demand for the kits surged twentyfold.
The timing of the study matters. Irvine chose to examine 2019 through 2024 deliberately—years that bracketed the COVID-19 pandemic's disruption to every system of care, and coincided with an increasingly lethal illicit drug supply. It was also the period when B.C. saw its highest death rates since declaring a public health emergency a decade earlier. The year 2023 marked the worst: 2,593 deaths. Yet without the harm reduction infrastructure in place, Irvine noted, the numbers would have climbed even higher.
The research looked beyond naloxone alone. It examined the combined effect of take-home kits, overdose prevention sites, supervised consumption sites, and opioid agonist treatment—the full ecosystem of harm reduction. When kits were distributed through overdose prevention and supervised consumption sites, they were far more likely to be deployed in an actual emergency. Community programs alone, the study found, averted roughly 1,000 death events per 100,000 people at risk.
Irvine acknowledged the difficulty in conveying impact when headlines focus only on rising death tolls. "It's really trying to look in combination across all of these harm reduction services to see what sort of an impact they had," he said. The study's purpose was partly to quantify what might otherwise remain invisible—the lives saved by prevention, not just the lives lost to overdose.
When asked whether the research might shift public perception of harm reduction, Irvine was measured. The question, he suggested, was larger than any single study could answer. Public health decisions require tough choices, and evidence matters—both for policymakers and for the public trying to understand what these interventions actually accomplish. "I think it can only be better with more evidence and more data available," he said.
Recent months offer a glimmer of momentum. The B.C. Coroners Service reported 522 fatal overdoses in the first four months of 2026, down from 617 in the same period of 2025 and 840 in early 2024. Nationally, opioid-related deaths fell 23 percent from 2024 to 2025. Canada's chief public health officer, Dr. Joss Reimer, attributed the decline to expanded naloxone access and better surveillance of illicit drug supplies. But she offered a cautionary note: the illegal drug supply remains toxic and unpredictable, and the progress, while real, remains fragile.
Citas Notables
It's really trying to look in combination across all of these harm reduction services to see what sort of an impact they had.— Dr. Mike Irvine, BCCDC
The progress remains fragile. Illegal drug supply remains toxic and unpredictable.— Dr. Joss Reimer, Canada's chief public health officer
La Conversación del Hearth Otra perspectiva de la historia
Why focus the study on those specific five years? Why not look at the entire history of the program since 2012?
Those years captured something crucial—the pandemic's chaos and the drug supply becoming genuinely more lethal at the same time. It's the worst-case scenario, in a way. If harm reduction worked then, it works.
The 78 percent figure is striking. But what does that actually mean in human terms?
It means that out of every 100 overdoses that would have been fatal without intervention, 78 people walked away alive. In the study period, that's thousands of people. Mothers, workers, neighbors.
You mentioned the kits are more likely to be used when distributed through supervised consumption sites. Why is location so important?
Because the person holding the kit is already in a space where overdose is a known risk. They're not carrying it as a theoretical precaution. They're there because they use, and they know the people around them. It's proximity to actual need.
Does this study settle the debate about harm reduction?
No. Irvine was honest about that. A study can show what works, but it can't resolve the deeper question of how a society chooses to respond to addiction. Evidence is necessary but not sufficient.
The death numbers are still climbing year to year until 2023. How do you square that with the idea that harm reduction is working?
It's like asking why a dam is necessary if water still flows over it. The interventions prevented a catastrophe that would have been worse. Without them, 2023 would have been even deadlier.
What's the fragility Reimer mentioned?
The drug supply itself. Naloxone saves lives in the moment, but it doesn't change what's in the drugs. If the supply becomes more toxic, or if access to naloxone shrinks, the gains disappear quickly.